Mitoxantrone Terminated Phase 1 / 2 Trials for Leukemias Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00882076Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias